Ugur Sahin,Ozlem Tureci,Gunda Brandenburg,Dirk Usener
申请号:
US12601488
公开号:
US08425902B2
申请日:
2008.05.27
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, cancer of the gallbladder, and the metastases thereof.